KVUE
Kenvue
Consumer Staples · Personal Care Products · US
$17.71
Data: 2026-05-15
✓ ETHICAL PASS

MODERATE MOAT
HIGH
Data Confidence: 100.0%
Key Metrics

How this company measures up on the fundamentals that matter

Market Cap
$32.8B
Total market value of the company
Trailing P/E
20.36
Premium valuation
Forward P/E
13.82
Based on estimated future earnings — lower means cheaper
Rev Growth
+4.5%
Year-over-year revenue change
Profit Margin
10.6%
How much profit the company keeps from each dollar of revenue
ROE
15.7%
Return on equity — how efficiently it uses shareholder money
Analyst Target
$19.50
+10% from current price — median analyst estimate
Recommendation
HOLD
Consensus view from 12 analysts covering this stock
About Kenvue

Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.

https://www.kenvue.com

Country: United States Employees: 21,780 Industry: Household & Personal Products
Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity
PASS
Core business does not involve prohibited activities
Debt Ratio
32.0% PASS
Debt must be below 33% of total assets
Cash Ratio
0.0% PASS
Interest-bearing cash below 33% of assets
Receivables
12.7% PASS
Receivables below 49% of assets
Revenue Purity
0.3% PASS
Non-compliant revenue below 5% — any excess requires purification
Valuation
Fair Value Est.
$14.86
What our model estimates this business is worth per share
Margin of Safety
-19.2%
Trading above fair value — no margin of safety
Rating
OPPORTUNITY
Overall assessment combining ethics, valuation, and quality
Percentile
96.7th
Ranks in the top 3% of our 13,571 screened universe
Ethical Score
83.8
Valuation Score
71.5
Quality Score
68.3
Combined
72.7

Trading at $17, 15% above fair value of $15. Moderate competitive position. Passes all ethical screens. Ranks better than 95% of screened stocks.

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime
ACCUMULATION
Smart money appears to be building positions quietly
Sharpe Ratio
0.128
Positive but modest risk-adjusted returns
Kelly Fraction
-0.0072
No positive edge detected — the data suggests staying out
Calmar Ratio
-0.017
Drawdown risk outweighs the returns — higher risk profile
Annual Return
-0.7%
Historical annualised return based on price data
Max Drawdown
-41.2%
Largest peak-to-trough decline — the worst it has been
HMM State
BULL
Statistical model sees bullish momentum
Days in State
4
How long the current regime has persisted — longer means more stable
Market Data

Trading characteristics and market positioning

Beta
0.52
Less volatile than the market — more defensive
52W High
$24.36
27% below the year high
52W Low
$14.02
26% above the year low
Avg Volume
23,357,070
Average daily shares traded — higher means easier to buy and sell
Short Ratio
3.2
Days it would take all short sellers to cover — higher means more crowded
Short % Float
3.4%
Low short interest — limited bearish positioning
Div Yield
4.8%
Annual dividend as a percentage of the share price
EPS (TTM)
$0.84
Earnings per share over the last 12 months
Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity
0.83
Moderate leverage — manageable
Current Ratio
0.98
Below 1 means short-term obligations exceed liquid assets — risk flag
Quick Ratio
0.61
Like current ratio but excludes inventory — stricter test
Gross Margin
58.6%
Revenue left after cost of goods — higher means pricing power
Operating Margin
21.6%
Profit from core operations before interest and tax
Free Cash Flow
$1.9B
Positive — the business generates more cash than it spends
Revenue (TTM)
$15.3B
Total revenue over the last 12 months
Net Income
$1.6B
Profitable — the bottom line is positive
Analyst Coverage
Analysts
12
Target High
$23.00
Target Median
$19.50
Target Low
$18.00
Recent Insider Activity

SEC Form 4 filings — what company insiders are buying and selling

Date Insider Title Type Shares Value
2026-05-08 ORLANDO MATTHEW General Counsel 38,491 $679,691
2026-03-10 STEVENS MEREDITH Chief Operating Officer 5,169 —
2026-03-10 ALVARADO LUANI Chief Operating Officer 4,222 —
2026-03-10 LAWSON CARLTON Officer 6,157 —
2026-03-05 HOWLETT HEATHER Officer 2,722 —
2026-03-05 STEVENS MEREDITH Chief Operating Officer 6,178 —
2026-03-05 ALVARADO LUANI Officer 4,289 —
2026-03-05 LAWSON CARLTON Officer 7,736 —
2026-03-03 HOWLETT HEATHER Officer 1,534 —
2026-02-13 HOWLETT HEATHER Officer 13,571 —
Source: SEC Form 4 filings via public data. View all insider activity at
Insider Intelligence
Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-15

Discover More
Alpha Insights Market Intelligence Titan Watch Ethical Screener Insider Intelligence Track Record Ethical Finance Zakat Calculator Iran Oil Tracker Foundry (292 articles) Indicators Join Free →

Get our weekly market brief free.